In February 2026, a second patient at Harborview Medical Center in Seattle successfully received the Brain Interchange™ implant as part of an NIH-funded, FDA-approved trial led by researchers from the University of Washington and UCLA. Building on encouraging results from the first participant, the study continues to advance CorTec’s clinical program for stroke recovery.
